CliffBio
small molecule

IMPOYZ

CLOBETASOL PROPIONATE

Loss of exclusivityMarch 2035latest FDA-listed patent expiry
CompanyPrimus Pharmaceuticals →View the full company profile on CliffBio

Drug detail

Brand nameIMPOYZ
Active ingredientCLOBETASOL PROPIONATE
Strength0.025%
Dosage formCREAM
RouteTOPICAL
ModalitySmall molecule
FDA approvalNovember 2017
Marketing statusRX

Listed patents

PatentExpiresType
9855334March 2035product
10064875August 2030product
9956231August 2030product
11179465August 2030product
10588914August 2030product

More from Primus Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

IMPOYZ patent cliff — loss of exclusivity March 2035 | CliffBio